1World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications.Report of a WHO consultation, 1999, Geneva.
2Expert Panel on Detection, of High Blood Cholesterol Evaluation, and Treatment in Adults. Executive Summary of the Third Report of The National Cholestero Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cho lesterol In Adul.ts (Adult Treatment Panel Ⅲ ). JAMA, 2001, 285(19) :2486-2497.
6Tuomilehto J, LinastrOm J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med, 2001, 344(18):1343-1350.
7Third Report of the National Cholesterol Education Program(NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel Ⅲ) final report. Circulation, 2002, 106:3143-3421.
8Israili ZH, Lyoussi B, Herndndez-Herndndez R, et al. Metabolic syndrome: treatment of hypertensive patients. AmJ Ther, 2007, 14(4) :386-402.
9M, Kusuyama T, Shigemitsu M, Fukui T, et al. A randomized comparison of pioglitazone to inhibit restenosis after coronary stenting in patients with type 2 diabetes. Diabetes Care, 2006, 29(1) :101-106.
2Reaven G. The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, and different goals. Endocrinol Metab Clin North Am, 2004, 33:283-303.
3Valle M, Martos R, Gascon F, et al. Low-grade systemic inflammation, hypoadiponectinemia and a high concentration of leptin are present in very young obese children, and correlate with metabolic syndrome. Diabetes Metab, 2005,31:55-62.
4Turek F W, Joshu C, Kohsaka A, et al. Obesity and metabolic syndrome in circadian clock mutant mice. Science, 2005,21:357-362.
5McNeill A M, Rosamond W D, Girman C J, et al. The meatabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care, 2005,28:385-390.
6Caglayan E, Blaschke F, Takata Y, et al. Metabolic syndrome-interdependence of the cardiovascular and metabolic pathways. Curr Opin Pharmacol, 2005,5:135-142.
7Isomaa B. A major health hazard: the metabolic syndrome. Life Sci, 2003,73:2395-2411.
8Pereira M A, Jacobs D R Jr, Van Horn L, et al. Dairy consumption, obesity, and the insulin resistance syndrome in young adults: the CARDIA Study. JAMA,2002 ,287:2081-2089.
9Dixon J B, Dixon M E, OBrien P E. Alcohol consumption in the severely obese: relationship with the metabolic syndrome. ObesRes, 2002 ,10:245-252.
10Grundy S M, Abate N, Chandalia M. Diet composition and the metabolic syndrome: what is the optimal fat intake? Am J Med, 2002,113 (Suppl 9B) :25S-29S.
3BUSE J B. Primary prevention of cardiovascular disease with dia- betes mellitus: a scientific statement from association and the American diabetes association[J]. Diabetes Care, 2007, 30(7) : 162 - 163.
